333 related articles for article (PubMed ID: 15589579)
1. Establishment of subrenal capsule xenografts of primary human ovarian tumors in SCID mice: potential models.
Lee CH; Xue H; Sutcliffe M; Gout PW; Huntsman DG; Miller DM; Gilks CB; Wang YZ
Gynecol Oncol; 2005 Jan; 96(1):48-55. PubMed ID: 15589579
[TBL] [Abstract][Full Text] [Related]
2. Establishment in severe combined immunodeficiency mice of subrenal capsule xenografts and transplantable tumor lines from a variety of primary human lung cancers: potential models for studying tumor progression-related changes.
Cutz JC; Guan J; Bayani J; Yoshimoto M; Xue H; Sutcliffe M; English J; Flint J; LeRiche J; Yee J; Squire JA; Gout PW; Lam S; Wang YZ
Clin Cancer Res; 2006 Jul; 12(13):4043-54. PubMed ID: 16818704
[TBL] [Abstract][Full Text] [Related]
3. Effects of IL-12 on human ovarian tumors engrafted into SCID mice.
Silver DF; Hempling RE; Piver MS; Repasky EA
Gynecol Oncol; 1999 Feb; 72(2):154-60. PubMed ID: 10021294
[TBL] [Abstract][Full Text] [Related]
4. Establishment and characterization of human urothelial cancer xenografts in severe combined immunodeficient mice.
Abe T; Tada M; Shinohara N; Okada F; Itoh T; Hamada J; Harabayashi T; Chen Q; Moriuchi T; Nonomura K
Int J Urol; 2006 Jan; 13(1):47-57. PubMed ID: 16448432
[TBL] [Abstract][Full Text] [Related]
5. Characterization of human ovarian carcinomas in a SCID mouse model.
Xu Y; Silver DF; Yang NP; Oflazoglu E; Hempling RE; Piver MS; Repasky EA
Gynecol Oncol; 1999 Feb; 72(2):161-70. PubMed ID: 10021295
[TBL] [Abstract][Full Text] [Related]
6. [Establishment and comparison of two intraperitoneally transplanted human ovarian carcinoma models with immune reconstitution in severe combined immunodeficient mice].
Li Y; Cui H; Chang XH; Feng J; Fu TY; Feng YJ; Wei LH
Ai Zheng; 2004 Feb; 23(2):160-4. PubMed ID: 14960235
[TBL] [Abstract][Full Text] [Related]
7. Establishment and characterization of in vivo human tumor models in the NOD/SCID/gamma(c)(null) mouse.
Fujii E; Suzuki M; Matsubara K; Watanabe M; Chen YJ; Adachi K; Ohnishi Y; Tanigawa M; Tsuchiya M; Tamaoki N
Pathol Int; 2008 Sep; 58(9):559-67. PubMed ID: 18801070
[TBL] [Abstract][Full Text] [Related]
8. Tumor-associated glycoprotein (TAG-72) in ovarian carcinomas defined by monoclonal antibody B72.3.
Thor A; Gorstein F; Ohuchi N; Szpak CA; Johnston WW; Schlom J
J Natl Cancer Inst; 1986 Jun; 76(6):995-1006. PubMed ID: 3520078
[TBL] [Abstract][Full Text] [Related]
9. A four-day subrenal capsule assay for testing the effectiveness of anticancer drugs against human tumors.
Levi FA; Blum JP; Lemaigre G; Bourut C; Reinberg A; Mathé G
Cancer Res; 1984 Jun; 44(6):2660-7. PubMed ID: 6722799
[TBL] [Abstract][Full Text] [Related]
10. Overexpression of mammaglobin B in epithelial ovarian carcinomas.
Tassi RA; Bignotti E; Rossi E; Falchetti M; Donzelli C; Calza S; Ravaggi A; Bandiera E; Pecorelli S; Santin AD
Gynecol Oncol; 2007 Jun; 105(3):578-85. PubMed ID: 17343903
[TBL] [Abstract][Full Text] [Related]
11. [The analysis of tumor growth rate and histopathology of xenografts of nude mice bearing human ovarian carcinoma in immunocompetent mice].
Wang J; Qian H; Li W
Zhonghua Fu Chan Ke Za Zhi; 1995 Mar; 30(3):157-60. PubMed ID: 7796649
[TBL] [Abstract][Full Text] [Related]
12. Treatment of chemotherapy-resistant human ovarian cancer xenografts in C.B-17/SCID mice by intraperitoneal administration of Clostridium perfringens enterotoxin.
Santin AD; Cané S; Bellone S; Palmieri M; Siegel ER; Thomas M; Roman JJ; Burnett A; Cannon MJ; Pecorelli S
Cancer Res; 2005 May; 65(10):4334-42. PubMed ID: 15899825
[TBL] [Abstract][Full Text] [Related]
13. Flt-3 ligand inhibits growth of human ovarian tumors engrafted in severe combined immunodeficient mice.
Silver DF; Hempling RE; Piver MS; Repasky EA
Gynecol Oncol; 2000 Jun; 77(3):377-82. PubMed ID: 10831345
[TBL] [Abstract][Full Text] [Related]
14. Establishment of human tumor xenografts in immunodeficient mice.
Morton CL; Houghton PJ
Nat Protoc; 2007; 2(2):247-50. PubMed ID: 17406581
[TBL] [Abstract][Full Text] [Related]
15. [Clinicopathologic analysis and expression of cyclin D1 and p53 of ovarian borderline tumors and carcinomas].
Shao HL; Shen DH; Xue WC; Li Y; Yu YZ
Zhonghua Fu Chan Ke Za Zhi; 2007 Apr; 42(4):227-32. PubMed ID: 17631760
[TBL] [Abstract][Full Text] [Related]
16. Cytokeratins 7 and 20 in primary and secondary mucinous tumors of the ovary: analysis of coordinate immunohistochemical expression profiles and staining distribution in 179 cases.
Vang R; Gown AM; Barry TS; Wheeler DT; Yemelyanova A; Seidman JD; Ronnett BM
Am J Surg Pathol; 2006 Sep; 30(9):1130-9. PubMed ID: 16931958
[TBL] [Abstract][Full Text] [Related]
17. Effects of recombinant human erythropoietin on the antitumor effect of cisplatin in SCID mice bearing human ovarian cancer: A possible oxygen effect.
Silver DF; Piver MS
Gynecol Oncol; 1999 May; 73(2):280-4. PubMed ID: 10329047
[TBL] [Abstract][Full Text] [Related]
18. Development of metastatic and non-metastatic tumor lines from a patient's prostate cancer specimen-identification of a small subpopulation with metastatic potential in the primary tumor.
Lin D; Bayani J; Wang Y; Sadar MD; Yoshimoto M; Gout PW; Squire JA; Wang Y
Prostate; 2010 Nov; 70(15):1636-44. PubMed ID: 20564316
[TBL] [Abstract][Full Text] [Related]
19. Placental leucine aminopeptidase (P-LAP) and glucose transporter 4 (GLUT4) expression in benign, borderline, and malignant ovarian epithelia.
Shibata K; Kajiyama H; Mizokami Y; Ino K; Nomura S; Mizutani S; Terauchi M; Kikkawa F
Gynecol Oncol; 2005 Jul; 98(1):11-8. PubMed ID: 15907336
[TBL] [Abstract][Full Text] [Related]
20. Ovarian mature teratomas with mucinous epithelial neoplasms: morphologic heterogeneity and association with pseudomyxoma peritonei.
McKenney JK; Soslow RA; Longacre TA
Am J Surg Pathol; 2008 May; 32(5):645-55. PubMed ID: 18344868
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
